Current Diabetes Reviews
Title:Meet Our Editorial Board Member:
Volume: 11 Issue: 4
Author(s): Carlos A. Aguilar Salinas
Affiliation:
Export Options
About this article
Cite this article as:
A. Aguilar Salinas Carlos, Meet Our Editorial Board Member:, Current Diabetes Reviews 2015; 11 (4) . https://dx.doi.org/10.2174/157339981104150729102813
DOI https://dx.doi.org/10.2174/157339981104150729102813 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tissue Biomarkers for Prostate Cancer Radiation Therapy
Current Molecular Medicine Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity
Current Neuropharmacology Clinically Relevant Extracellular-Matrix Scaffolds for Cell Transplantation and Vascular Repair
Current Vascular Pharmacology Recent Advances in Gut Nutrient Chemosensing
Current Medicinal Chemistry The Effect of Dual-Task Testing on Balance and Gait Performance in Adults with Type 1 or Type 2 Diabetes Mellitus: A Systematic Review
Current Diabetes Reviews Overview: Antioxidants: A “Higgs Boson” in Animal Health and Production
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry Overuse of PPIs in Patients at Admission, During Hospitalisation, and at Discharge in a Terciary Spanish Hospital
Current Clinical Pharmacology HIV-Therapy Associated Lipodystrophy: Experimental and Clinical Evidence for the Pathogenesis and Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets Diagnostic and Therapeutic Use of Human Recombinant Thyrotropin (rhTSH)(Thyrogen®) in Well-Differentiated Thyroid Cancer - Current Indications and Future Perspectives - A Review
Current Pharmaceutical Analysis Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study
Current Vascular Pharmacology DMBA- Induced Breast Cancer: A Hormonal Camouflage
Current Cancer Therapy Reviews Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
Current Pharmaceutical Design Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Current Genomics Prediction of Activities of BRAF (V600E) Inhibitors by SW-MLR and GA-MLR Methods
Current Computer-Aided Drug Design Editorial [Hot topic:Expression and Refolding Technologies for Production of Recombinant Proteins (Guest Editors: Tsutomu Arakawa and Kouhei Tsumoto)]
Current Pharmaceutical Biotechnology Endocrine-Disrupting Compounds in Fish Physiology, with Emphasis on their Effects on the Arginine Vasotocin/Isotocin System
Endocrine, Metabolic & Immune Disorders - Drug Targets Design and Development of Oral Nanoparticulated Insulin in Multiple Emulsion
Current Drug Delivery Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination with Checkpoint Inhibitors and Beyond
Current Drug Targets Crosstalk Between The Immune Receptors and Gut Microbiota
Current Protein & Peptide Science